Villafranca Piemonte, Italy

Chiara Lorenzetto

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 69(Granted Patents)


Location History:

  • Villafranca Plemonte, IT (2013)
  • Turin, IT (2015)
  • Villafranca Piemonte, IT (2009 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Chiara Lorenzetto: Innovator in Polymer Conjugates

Introduction

Chiara Lorenzetto is a prominent inventor based in Villafranca Piemonte, Italy. She has made significant contributions to the field of polymer conjugates, holding a total of 6 patents. Her work focuses on innovative solutions for diagnosing and treating various pathologies.

Latest Patents

One of her latest patents involves the development of polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1. This invention relates to novel polymer conjugates of polypeptide variants of the HMGB1 high affinity binding domain Box-A. The invention also concerns the use of these polymer conjugates to diagnose, prevent, alleviate, and treat pathologies associated with extracellular HMGB1 and increased expression of RAGE. Another significant patent is the synthesis of polymer conjugates of indolocarbazole compounds. This process focuses on preparing polymer conjugates of K-252a and its derivatives through a synthetic route that ensures high purity and yield.

Career Highlights

Chiara has worked with notable companies such as Creabilis Therapeutics S.p.a. and Creabilis Therapeutics S.r.l. Her expertise in polymer chemistry has positioned her as a key player in the development of therapeutic solutions.

Collaborations

Throughout her career, Chiara has collaborated with esteemed colleagues, including Silvano Fumero and Silvio Traversa. These partnerships have enhanced her research and contributed to her innovative projects.

Conclusion

Chiara Lorenzetto's work in polymer conjugates showcases her dedication to advancing medical science through innovation. Her patents reflect her commitment to addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…